Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5271 USD | -3.94% | -9.51% | +93.08% |
Apr. 09 | Brainstorm Cell Therapeutics Says FDA Agrees on Design of Phase 3B ALS Trial | MT |
Apr. 09 | Transcript : Brainstorm Cell Therapeutics Inc. - Special Call |
- Stock Market
- Equities
- BCLI Stock
- News Brainstorm Cell Therapeutics Inc.